Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Have you ever forgotten something so simple and mundane like what you ate the other day repeatedly? If the answer is yes, ...

Researchers from the Alzheimer's Center at Temple (ACT) provide new insights into how microglia, the brain's immune cells, ...

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...

Older adults with comorbid AD and diabetes face compounding adverse effects on blood pressure, medication use, and mental health.

Algal bloom triggered by sewage discharges could be causing in dolphins the same form of brain degeneration seen in humans ...